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transduction is regulated and compartmentalized in the
cilium or flagellum membrane, in the absence of the
specialized domains and machinery known to control
signaling at the membrane of the rest of the cell (i.e.,
coated pits, membrane vesicular structures, etc.). In
addition, these data have major implications for the
understanding of signal transduction in the mammalian
cilium. This is an especially important issue in light of
recent results demonstrating that PDGF-A, Sonic
hedgehog (Shh), and possibly many other pathways
require cilia for normal activity (Haycraft et al., 2005;
Pazour and Witman, 2003; Schneider et al., 2005). For
example, recent reports have revealed that Smooth-
ened, a transmembrane protein involved in the Hedge-
hog pathway, translocates to the cilia in the presence
of Shh and that all three of Hedgehog’s Gli-type tran-
scriptional effectors localize to a domain at the tip of
the cilium (Corbit et al., 2005; Haycraft et al., 2005;
Huangfu and Anderson, 2006). Thus, it has been specu-
lated that the tip of the cilium is a specialized compart-
ment where ligand-induced modifications of the Gli
proteins occur in response to Shh. Indeed, loss of cilia
is known to inhibit Gli2 activity and processing of Gli3;
however, due to the limitations of the mammalian sys-
tem, it is not yet feasible to evaluate direct involvement
of IFT proteins in this process. It is tempting to specu-
late that, as seen for PKG in Chlamydomonas, there is
an IFT-dependent recompartmentalization of the Gli
proteins (or equivalent proteins in other pathways) in
response to ligand that regulates pathway activity.
Overall, the data in the Wang et al. (2006) publication
will have a major impact on how we perceive the func-
tions of IFT in some of the most critical pathways re-
quired for normal development and tissue homeostasis
in postnatal life.
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542Grasp a pTyr-Peptide by Its SOCS
Signaling via suppressors of cytokine signaling
(SOCS) is an important negative feedback system for
cytokine-mediated signal transduction. Recently in
Molecular Cell, Babon et al. (2006) described the ter-
tiary structure of SOCS3 in complex with a phospho-
tyrosine-containingpeptide from the IL-6 receptor sub-
unit gp130, and they identified the specific amino acids
that are critical for binding.
Cytokines are secreted glycoproteins that play crucial
roles in development, immune responses, hematopoie-
sis, endocrine function, inflammatory responses, and
a variety of diseases. Binding of cytokines to their recep-
tors results in the oligomerization of receptor subunits
and activation of the Janus family tyrosine kinases
(JAK) constitutively associated with receptors. Subse-
quent tyrosine phosphorylation of receptor cytoplasmic
domains gives rise to the formation of SH2 domain bind-
ing sites for a variety of signaling molecules. One of the
major signaling molecules in cytokine signaling is the
‘‘signal transducers and activators of transcription’’(STAT) family of latent transcriptional factors (STAT1-
6). STATs recruited to the receptors are then tyrosine
phophorylated by JAKs and translocated to the nucleus
to induce transcription of target genes (Sehgal et al.,
2003) (Figure 1A). Since prolonged and enhanced activa-
tion of cytokine signaling causes detrimental biological
consequences including autoimmune and inflammatory
disease, the pathway must be tightly regulated. One
feedback inhibitor induced by STATs is called ‘‘suppres-
sor of cytokine signaling’’ (SOCS).
The SOCS family consists of eight members: SOCS1–
SOCS7 and cytokine inducible SH2 protein (CIS) (Alex-
ander and Hilton, 2004; Elliott and Johnston, 2004;
Yasukawa et al., 2000). SOCS family members share
a common architecture, including a central SH2 domain
and a C-terminal SOCS box. In addition, SOCS3 has
a 12 residue kinase inhibitory region (KIR) followed by
an extended SH2 subdomain (ESS) (Figure 1A). Thus, in-
duced SOCSs inhibit cytokine signaling, although the
mode of the inhibition can vary among family members.
For example, SOCS1 directly binds to JAK, while
SOCS3 uses its SH2 domain to bind phosphorylated ty-
rosine (pTyr) residues in receptors such as gp130 (Y759),
LeptinR (Y985), and EpoR (Y401), just as SOCS2 binds
to Y595/Y487 of the growth hormone (GH) receptor.
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543Figure 1. SOCS3 Is a Critical Negative Regu-
lator of IL-6-Mediated Signaling
(A) Y767, Y814, Y905, and Y915 are STAT3
binding pTyr of human gp130. Y759 (or Y757
of mouse gp130) is the SOCS3 binding pTyr.
(B) View showing SOCS3 binding the corre-
sponding gp130-derived pTyr-peptide.Once incorporated into the receptor complex, SOCS3
inhibits JAK kinase activity through its KIR domain. In
addition, the SOCS box recruits the ubiquitin-transfer-
ase system and thereby functions as an E3 ubiquitin
ligase to degrade other signaling molecules associated
with SOCS N-terminal regions.
The importance of SOCS-mediated negative feedback
has been well established in knockout mice; severe
inflammatory disease due to enhanced IFNg signaling,
gigantism due to enhanced GH signaling, and placental
defects due to enhanced LIF signaling have been ob-
served in SOCS12/2, SOCS22/2, and SOCS32/2 mice,
respectively (Alexander and Hilton, 2004; Elliott and
Johnston, 2004). Knockin mice expressing mutant gp130
where the SOCS3 binding site, tyrosine 759, is replaced
with phenylalanine (gp130Y759F/Y759F or Y759F or just
F759 mice) show enhanced and prolonged activation of
STAT3, resulting in spontaneous development of rheu-
matoid arthritis-like autoimmune joint disease as they
age (Atsumi et al., 2002). SOCS3 is a negative regulator
of the IL-6 family cytokines, which utilize gp130 as recep-
tor subunit (Figure 1A). The IL-6/gp130/JAK/STAT3 sig-naling pathway is conserved among vertebrates and in-
vertebrates; in Drosophila, the corresponding cytokine,
receptor, JAK, and STAT proteins are named Unpaired
(Upd), Domeless (Dome), Hopscotch (Hop), and Stat92E,
respectively (Hou et al., 2002; Sehgal et al., 2003). Three
SOCS-like genes have also been identified inDrosophila
and are hypothesized to inhibit Stat92E-mediated sig-
naling. The Upd/Dome/Hop/Stat92E pathway plays cru-
cial roles in development, including sex determination,
oogenesis, segmentation, and planar cell polarity deter-
mination. In zebrafish, STAT3 controls epithelial-mesen-
chymal transitions (EMT) and cell polarity determination
during gastrulation (Miyagi et al., 2004; Yamashita et al.,
2002, 2004). Thus, IL-6/gp130/JAK/STAT3 signaling
plays crucial roles in the regulation of cell proliferation,
differentiation, survival, and movement in response to
a variety of cytokines and growth factors in various bio-
logical processes including gastrulation, organogene-
sis, and wound healing, and its dysregulation is involved
in a variety of diseases, such as cancer and inflammatory
diseases (Sehgal et al., 2003). In this sense, it is crucial to
clarify the molecular mechanisms of each component
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544signaling molecule, such as SOCS3. Extensive mutagen-
esis studies involving SOCS3 have been done, but until
recently, no structural information was available for any
member of the SOCS family.
Norton and colleagues have for the first time deter-
mined the solution tertiary structure of SOCS3 in com-
plex with a pTyr-containing peptide from gp130 (Babon
et al., 2006). They showed that seven amino acid resi-
dues of gp130 form a hydrophobic SOCS3 binding motif
(Figure 1B), while the SH2 domain that binds it is com-
prised of SOCS3 residues Gly45–Asn185. This SH2
domain consists of a central b sheet flanked by an a helix
on each face, followed by an unstructured PEST insert of
35 residues and then by the hydrophobic BG loop, which
directly contacts the gp130 pTyr peptide. The PEST
insert is not critical structurally but regulates protein
stability, most likely via a proteasome-independent
mechanism. The importance of the ESS for SOCS30s
binding to gp130 was previously reported, but the struc-
tural basis of this requirement was not known. Norton
and colleagues show that the ESS and the C-terminal
half of the KIR are packaged into a single 15 residue
a helix immediately N-terminal to the SH2 domain. The
hydrophobic side of this amphipathic a helix stacks
onto the SH2 domain’s central b sheet, on the far side
of the pTyr binding site. It also makes direct contacts
with the pTyr binding loop and contributes to the loop’s
geometry. This structure suggests that the SH2-ligand
interaction may affect the KIR domain’s interaction with
JAK or vice versa, revealing a basis for understanding
how interactions between the SH2 domain and its flank-
ing regions can coordinate binding of target molecules.
The sequence of the pTyr binding loop of the SOCS3
SH2 domain is conserved in almost all species. This
may suggest that the pTyr-containing ligands for the
SOCS3 SH2 domain might have a conserved structure.
It is reported that SOCS3 binds not only gp130 (Y759)
but also Leptin receptor (Y985) and EpoR (Y401). In fact,
the amino acid residues by which these cytokine recep-
tors bind to SOCS3 are conserved (the 22 and +3 posi-
tions relative to the tyrosineare hydrophobic amino acids
in three receptors, while the +4 position is hydrophobic in
the leptin receptor and in gp130 [Figure 1B]), supporting
the idea that the cytokine receptor family ligands of
SOCS3 have a conserved structure. The sequence of
SOCS proteins (SOCS1–SOCS7) is also conserved from
the C-terminal half of the KIR and ESS domain throughDevelopmental Cell 10, May, 2006 ª2006 Elsevier Inc. DOI 10.1016/j.d
Sister Chromatid Cohesion at the
Centromere: Confrontation between
Kinases and Phosphatases?
Accurate chromosome segregation in mitosis and
meiosis requires that the cohesin complex be pro-
tected at the centromere by the Shugoshin/MEI-S332the SH2 domain, including the pTyr binding loop. There-
fore, it is possible that the binding geometry between
SOCS family members and their ligands is conserved.
The work of Norton and colleagues thus establishes
a structural basis for the artificial design of SOCS inhibi-
tors and other regulators of cytokine signaling. Indeed,
by using peptide fragments of SOCS SH2 domains or
their phosphotyrosine ligands, we may gain control of
a variety of SOCS-regulated signaling pathways relevant
to development, immunity, and cancer progression.
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protein family. Recent studies show that Sgo directly
binds the phosphatase PP2A, tethering it to the cen-
tromere where it can protect cohesin subunits from
phosphorylation, and that localization of Sgo/MEI-
S332 itself is regulated by phosphorylation.
Physical attachment, or cohesion, between centro-
meres of sister chromatids is essential for the two sister
